Skip to main content
Top

Drugs

Issue 8/2025

Content (10 Articles)

Rebound Pain After Peripheral Nerve Block: A Review

Wenqin Yin, Dan Luo, Haiqi Mi, Zhimin Ren, Lianling Li, Zhidong Fan, Jingyan Lin

Novel Potassium Binders in Reduction of Hyperkalemia and Optimization of RAAS Inhibitors Treatment in Patients with Chronic Kidney Disease or Heart Failure: A Systematic Review and Meta-analysis

Naya Huang, Yuanwen Xu, Chan Liu, Yuanying Liu, Yanping Fan, Zeyu Li, Dihua Zhang, Haiping Mao, Wei Chen

Efficacy and Safety of Plecanatide in Chinese Patients with Functional Constipation: A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Tao Bai, Zhiyue Xu, Yanbo Zhen, Aijun Liao, Bangmao Wang, Rong Zhao, Yin Zhu, Ning Dai, Side Liu, Hong Zhao, Xi Chen, Kunming Huang, Min Xu, Weizhen Zhou, Baohong Xu, Bin Ye, Duowu Zou, Heng Zhang, Ruihua Shi, Juan Zhang, Yaowei Ai, Xiangming Fang, Lin Lin, Xiaolan Zhang, Ling Zhang, Junping Wang, Yueping Jiang, Jun Cui, Mingxin Zhang, Xiangwu Ding, Zhongyin Zhou, Peng Yan, Xiaoqing Li, Bo Jiang, Youli Liu, Yingcai Ma, Shaoqi Yang, Xiaoyan Wang, Yongdong Wu, Jianjun Wu, Huixin Chen, Xiaohua Hou

Sipavibart: First Approval

Susan J. Keam

Limertinib: First Approval

  • NSCLC
  • AdisInsight Report

Arnold Lee

Tiratricol: First Approval

Yvette N. Lamb

Recaticimab: First Approval

Yvette N. Lamb

Fitusiran: First Approval

Arnold Lee

Correction: Mirdametinib: First Approval

  • Open Access
  • Correction

Sheridan M. Hoy